• Inducing Embryonic Dormancy via mTOR Inhibition: Protocol Ad

  2026-04-29

  This article reviews the protocol developed by Iyer et al. for inducing a reversible, diapause-like dormant state in mammalian early embryonic cells through mTOR inhibition. The approach offers a noninvasive, scalable alternative to traditional in vivo methods, with broad implications for developmental biology and reproductive technology.

• Toremifene Citrate: Applied Workflows in Estrogen Receptor R

  2026-04-28

  Toremifene Citrate stands out as a robust oral selective estrogen receptor modulator, enabling reproducible, high-fidelity estrogen receptor signaling studies. This guide delivers protocol-driven insights, troubleshooting tips, and practical workflow enhancements to help researchers maximize assay success using Toremifene Citrate from APExBIO.

• Synthetic Cleavage-Resistant TREM2 Enhances Macrophage Effer

  2026-04-28

  Dong et al. engineered a synthetic, cleavage-resistant TREM2 (CRT) receptor that sustains efferocytosis in inflammatory environments by resisting ADAM17-mediated shedding. Their macrophage-selective mRNA delivery approach led to in situ generation of CRT-expressing macrophages, reducing inflammation in mouse models of steatohepatitis and atherosclerosis.

• Exemestane in Translational Breast Cancer Research: Mechanis

  2026-04-27

  Explore how Exemestane, a steroidal aromatase inhibitor, advances translational breast cancer research. This article provides in-depth analysis of its mechanism, protocol optimization, and practical assay guidance not found elsewhere.

• Scenario-Driven Solutions in Antibacterial Assays with Gepot

  2026-04-27

  This article delivers evidence-based, scenario-driven insights for researchers performing cell viability, proliferation, and cytotoxicity assays using Gepotidacin (SKU BA1220). By addressing common laboratory challenges with quantitative data and validated protocols, the guide demonstrates how Gepotidacin enables reproducible, sensitive, and robust antibacterial research. Practical decision-making, protocol optimization, and vendor selection are all anchored to the unique properties of Gepotidacin.

• E-4031 in 3D Cardiac Electrophysiology: Mechanisms & Strateg

  2026-04-26

  Explore how E-4031, a benchmark hERG potassium channel blocker, is shaping the future of cardiac electrophysiology research. This thought-leadership article blends mechanistic depth with guidance for translational scientists, highlighting advances in 3D cardiac organoid modeling and high-content proarrhythmic risk assessment. Supported by recent innovations in shell microelectrode arrays and robust evidence, it provides a strategic roadmap for leveraging E-4031 in next-generation translational workflows.

• SMAD3 Inhibition Reduces ADAMTS-5 in Early Osteoarthritis Mo

  2026-04-25

  Xiang et al. provide mechanistic evidence that inhibiting SMAD3 upregulates miRNA-140, which in turn downregulates ADAMTS-5 expression in early osteoarthritis (OA). These findings advance understanding of cartilage degeneration and suggest new molecular targets for early OA intervention.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Pract

  2026-04-24

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) is formulated to prevent protein degradation during extraction and assay workflows without interfering with cation-dependent processes. It is best used in workflows such as Western blotting, co-immunoprecipitation, and kinase assays where broad-spectrum protease inhibition and EDTA exclusion are required. It should not be used in protocols that specifically require EDTA-mediated inhibition or where DMSO is incompatible.

• LINC02870 Drives SNAIL Translation and HCC Progression via E

  2026-04-24

  This study identifies the long non-coding RNA LINC02870 as an oncogenic driver in hepatocellular carcinoma (HCC) by enhancing SNAIL translation through interaction with EIF4G1. The findings illuminate a novel regulatory axis in HBV-related HCC metastasis and suggest new avenues for biomarker and therapeutic target development.

• Optimizing Genome Editing: EZ Cap™ Cas9 mRNA (m1Ψ) in Cell A

  2026-04-23

  This article provides an evidence-based, scenario-driven exploration of how EZ Cap™ Cas9 mRNA (m1Ψ) (SKU R1014) addresses common laboratory challenges in CRISPR-Cas9 genome editing. Researchers will gain practical insights on assay reproducibility, immune response suppression, and product selection, grounded in quantitative data and literature. Discover how SKU R1014 supports reliable, high-efficiency gene editing in mammalian systems.

• Methyl-β-cyclodextrin: Technical Use and Protocol Parameters

  2026-04-23

  Methyl-β-cyclodextrin (SKU C6939) is designed for selective extraction of cholesterol and certain lipids from cellular membranes, supporting membrane fluidity and lipid raft disruption studies. It is not suitable for diagnostic or medical applications and should be handled with strict attention to storage and preparation protocols for optimal experimental reliability.

• Trichostatin A (TSA): Protocols and Innovations in Cancer Ep

  2026-04-22

  Trichostatin A (TSA) stands out as a benchmark HDAC inhibitor, enabling researchers to dissect epigenetic regulation in cancer and immune models with precision. This article translates breakthrough workflows and troubleshooting tips into actionable guidance, highlighting TSA’s unique advantages as supplied by APExBIO.

• Diphenyleneiodonium Chloride: Strategic Insights for Transla

  2026-04-22

  This thought-leadership article provides translational researchers with a mechanistic and strategic synthesis of Diphenyleneiodonium chloride (DPI) as a dual-function probe in redox enzyme inhibition and cAMP signaling modulation. Drawing on recent literature, including the interplay between redox-sensitive transcription factors and viral pathogenesis, we dissect best practices, emerging challenges, and future horizons for DPI-guided workflows, while positioning APExBIO’s DPI as a tool of choice for innovative research.

• Superoxide Dismutase (SOD) Activity Assay Kit: Technical Gui

  2026-04-21

  The Superoxide Dismutase (SOD) Activity Assay Kit (K2035) provides a colorimetric, quantitative method for measuring SOD enzyme activity in biological fluids, supporting studies of oxidative stress and related pathways. It is best suited for research applications requiring reproducible, high-throughput assessment of antioxidative defense in cell, tissue, or plasma samples. This kit is not intended for diagnostic or clinical use.

• ABT-737: Precision BCL-2 Protein Inhibitor for Cancer Resear

  2026-04-21

  ABT-737 empowers researchers to induce apoptosis selectively in cancer cells by targeting BCL-2 family proteins. This guide translates cutting-edge in vitro methodologies and real-world troubleshooting strategies into actionable protocols for maximizing antitumor insights.

407 records 17/28 page Previous Next First page 上5页 1617181920 下5页 Last page